Glenmark Pharmaceuticals Q4 Loss widens
MM Desk
25 May, 2024
Glenmark Pharmaceuticals reported a significant widening of its loss for the quarter ended March 31,
Glenmark Pharmaceuticals reported a significant widening of its loss for the quarter ended March 31,
Astec Lifesciences, a subsidiary of Godrej Agrovet, revealed its financial results for the fourth quarter